Spitzweg Christine
Medizinische Klinik und Poliklinik II, Klinikum Grosshadern, München, Germany.
Z Arztl Fortbild Qualitatssich. 2004 May;98 Suppl 5:25-32.
The sodium iodide symporter (NIS) is an intrinsic plasma membrane protein mediating the active transport of iodide in the thyroid gland and a number of extrathyroidal tissues, in particular in the lactating mammary gland. Because of its crucial role for the ability of thyroid follicular cells to trap iodide, cloning of NIS opened up an exciting and extensive new field of thyroid-related research. Cloning and molecular characterisation of NIS allows investigation of its expression and regulation in thyroidal and non-thyroidal tissues and its potential pathophysiological and therapeutic implications in benign and malignant thyroid disease. In addition to its key function in thyroid physiology, NIS-mediated iodide accumulation allows both diagnostic thyroid scintigraphy and the effective therapeutic application of radioiodine in benign and malignant thyroid disease. Characterisation and application of NIS as a novel therapeutic gene for cytoreductive gene therapy of extra-thyroidal tumours and the presence of high endogenous NIS expression in the majority of breast cancers further suggest a promising role of NIS in the diagnosis and treatment of cancer outside the thyroid gland.
碘化钠转运体(NIS)是一种内在的质膜蛋白,介导甲状腺及许多甲状腺外组织(特别是哺乳期乳腺)中碘的主动转运。由于其对甲状腺滤泡细胞摄取碘的能力起着关键作用,NIS的克隆开启了一个令人兴奋且广泛的甲状腺相关研究新领域。NIS的克隆和分子特征分析有助于研究其在甲状腺组织和非甲状腺组织中的表达与调控,以及其在良性和恶性甲状腺疾病中的潜在病理生理和治疗意义。除了在甲状腺生理学中的关键作用外,NIS介导的碘积累使得甲状腺诊断性闪烁扫描以及放射性碘在良性和恶性甲状腺疾病中的有效治疗应用成为可能。将NIS作为一种新型治疗基因用于甲状腺外肿瘤的细胞减灭基因治疗的特征分析和应用,以及大多数乳腺癌中高内源性NIS表达的存在,进一步表明NIS在甲状腺外癌症的诊断和治疗中具有广阔前景。